Guidelines for the diagnosis of leukemia or lymphoma in children

Mary M. Zutter, Jay Hess

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Our progress in understanding and treating pediatric acute leukemia and lymphoma is one of the success stories of cancer biology and management. Event-free survival for children with acute leukemia or lymphoma has improved progressively during the past four decades. The advances in the cell and molecular biology of acute leukemia and lymphoma that have been made can help determine both prognosis and therapy; however, the pathologic evaluation of bone marrow and lymph node specimens must be directed appropriately to benefit from these advances. We present guidelines for the pathologic evaluation of bone marrow and lymph node specimens to maximize the chance that each patient will benefit from our increased understanding of these diseases.

Original languageEnglish (US)
JournalAmerican Journal of Clinical Pathology
Volume109
Issue number4 SUPPL. 1
StatePublished - Apr 1998
Externally publishedYes

Fingerprint

Lymphoma
Leukemia
Guidelines
Lymph Nodes
Bone Marrow
Disease-Free Survival
Cell Biology
Molecular Biology
Pediatrics
Neoplasms
Therapeutics

Keywords

  • Flow cytometry
  • Leukemia
  • Lymphoma
  • Pediatric

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Guidelines for the diagnosis of leukemia or lymphoma in children. / Zutter, Mary M.; Hess, Jay.

In: American Journal of Clinical Pathology, Vol. 109, No. 4 SUPPL. 1, 04.1998.

Research output: Contribution to journalArticle

@article{5eabef0a511245d3a5d34d97b85530cd,
title = "Guidelines for the diagnosis of leukemia or lymphoma in children",
abstract = "Our progress in understanding and treating pediatric acute leukemia and lymphoma is one of the success stories of cancer biology and management. Event-free survival for children with acute leukemia or lymphoma has improved progressively during the past four decades. The advances in the cell and molecular biology of acute leukemia and lymphoma that have been made can help determine both prognosis and therapy; however, the pathologic evaluation of bone marrow and lymph node specimens must be directed appropriately to benefit from these advances. We present guidelines for the pathologic evaluation of bone marrow and lymph node specimens to maximize the chance that each patient will benefit from our increased understanding of these diseases.",
keywords = "Flow cytometry, Leukemia, Lymphoma, Pediatric",
author = "Zutter, {Mary M.} and Jay Hess",
year = "1998",
month = "4",
language = "English (US)",
volume = "109",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "4 SUPPL. 1",

}

TY - JOUR

T1 - Guidelines for the diagnosis of leukemia or lymphoma in children

AU - Zutter, Mary M.

AU - Hess, Jay

PY - 1998/4

Y1 - 1998/4

N2 - Our progress in understanding and treating pediatric acute leukemia and lymphoma is one of the success stories of cancer biology and management. Event-free survival for children with acute leukemia or lymphoma has improved progressively during the past four decades. The advances in the cell and molecular biology of acute leukemia and lymphoma that have been made can help determine both prognosis and therapy; however, the pathologic evaluation of bone marrow and lymph node specimens must be directed appropriately to benefit from these advances. We present guidelines for the pathologic evaluation of bone marrow and lymph node specimens to maximize the chance that each patient will benefit from our increased understanding of these diseases.

AB - Our progress in understanding and treating pediatric acute leukemia and lymphoma is one of the success stories of cancer biology and management. Event-free survival for children with acute leukemia or lymphoma has improved progressively during the past four decades. The advances in the cell and molecular biology of acute leukemia and lymphoma that have been made can help determine both prognosis and therapy; however, the pathologic evaluation of bone marrow and lymph node specimens must be directed appropriately to benefit from these advances. We present guidelines for the pathologic evaluation of bone marrow and lymph node specimens to maximize the chance that each patient will benefit from our increased understanding of these diseases.

KW - Flow cytometry

KW - Leukemia

KW - Lymphoma

KW - Pediatric

UR - http://www.scopus.com/inward/record.url?scp=0031923667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031923667&partnerID=8YFLogxK

M3 - Article

C2 - 9533745

AN - SCOPUS:0031923667

VL - 109

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 4 SUPPL. 1

ER -